Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Annals of Surgical Oncology|September 27, 2007
The predictive value of ductography and magnetic resonance imaging in the management of nipple dischargeMary Morrogh, Elizabeth A Morris, Laura Liberman, et al.
Cancer|November 8, 2012
Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excisionMelissa P Murray, Chad Luedtke, Laura Liberman, et al.
AJR. American Journal of Roentgenology|December 24, 2010
Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-upNiamh M Hambly, Laura Liberman, D David Dershaw, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|April 26, 2017
Gateways to the Laboratory: How an MD-PhD Program Increased the Number of Minority Physician-ScientistsRuth Gotian, Jemella C Raymore, Shauna-Kay Rhooms, et al.
The Breast Journal|July 9, 2002
Histologic heterogeneity of masses at percutaneous breast biopsyElizabeth A Morris, Laura Liberman, Susan G Trevisan, et al.
AJR. American Journal of Roentgenology|July 24, 2003
Ductal enhancement on MR imaging of the breastLaura Liberman, Elizabeth A Morris, D David Dershaw, et al.
Cancer|July 23, 2003
Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk womenLaura Liberman, Elizabeth A Morris, Catherine L Benton, et al.
Annals of Surgical Oncology|November 21, 2007
MRI screening in a clinic population with a family history of breast cancerJeanne Yu, Anna Park, Elizabeth Morris, et al.
AJR. American Journal of Roentgenology|March 21, 2003
MR imaging of the ipsilateral breast in women with percutaneously proven breast cancerLaura Liberman, Elizabeth A Morris, D David Dershaw, et al.
Radiology|August 20, 2011
Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-upSandra B Brennan, Janice S Sung, D David Dershaw, et al.
Pageof 7